- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
Search this article
Description
<jats:title>Abstract</jats:title><jats:p>Memantine is an <jats:styled-content style="fixed-case">N</jats:styled-content>‐methyl‐<jats:styled-content style="fixed-case">D</jats:styled-content>‐aspartate glutamate receptor antagonist that may improve cognitive functions in patients with <jats:styled-content style="fixed-case">A</jats:styled-content>lzheimer's disease. It is predominantly excreted unchanged via the kidneys, and patients with decreased creatinine clearance must be treated with lower doses of memantine. However, it is unclear whether memantine itself can lead to renal dysfunction and/or hyperkalaemia. We report a patient with renal impairment and hyperkalaemia possibly associated with memantine administration.</jats:p>
Journal
-
- Psychogeriatrics
-
Psychogeriatrics 13 180-181, 2013-09-01
Wiley
